The National Plan of Vaccination was discussed by the Prime Minister of Georgia with a Designated Commission for the uninterrupted supply of vials at a meeting held today in the Government Administration.
Giorgi Gakharia spoke with officials directly engaged in the design of the plan about the stages of coverage and target groups, which will be immunized in the first instance.
It was noted at the meeting that the epidemic situation has been relatively stabilized as a result of the targeted restrictions currently imposed in the country, though it should not serve as a reason for relaxation as achievements need to be treasured.
In the opinion of the Head of Government of Georgia, sharp increase of community transfer rate should be avoided to allow for a gradual reopening of the economy and special attention is thus acquired by the synergy of several key measures: maintained trend of rising volume of testing, gradual and prudent easing of restrictions, as well as the actual vaccination. Giorgi Gakharia noted that consistent steps of the Government of Georgia are aimed at this very goal and the National Plan of Vaccination is part of them as the country should get technically ready for launching a nation-wide immunization.
As commonly known, the plan also covers logistical and operational issues related to the vaccination. According to experts and stakeholders engaged in the design of the plan, the document fully complies with the requirements of the World Health Organization (WHO). At the same time, priority groups defined in the plan meet the global standards and human rights.
The Head of Government of Georgia expressed his gratitude to every person engaged in the design and development of the National Plan of Vaccination, subject-matter professionals, Public Defender and donor agencies.
The National Plan of Vaccination will be endorsed by the Government of Georgia, upon which it will become publicly accessible.
At the same time, it was once again noted at the meeting that intensive work is in progress on supplying the country with vials as early as possible. Pre-requisite of this milestone achievement will be the international recognition of the vaccine by the WHO and global community.